Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Johns Hopkins University, Bristol-Myers must face 1 Billion Dollar syphilis infections suit

      Johns Hopkins University, Bristol-Myers must face 1 Billion Dollar syphilis infections suit

      Farhat Nasim5 Jan 2019 9:30 AM IST
      U.S: A federal judge in Maryland said The Johns Hopkins University, Bristol-Myers Squibb Co and the Rockefeller Foundation must face a $1 billion...
      Bristol-Myers Squibb buying Celgene in Rs 7400 crores deal

      Bristol-Myers Squibb buying Celgene in Rs 7400 crores deal

      Farhat Nasim5 Jan 2019 9:15 AM IST
      Shareholders of Bristol-Myers Squibb Co, based in New York City, would own about 69 per cent of the company, with Celgene shareholders owning about 31...
      Glenmark Pharma transfers API biz to Glenmark Life Sciences

      Glenmark Pharma transfers API biz to Glenmark Life Sciences

      Farhat Nasim5 Jan 2019 9:00 AM IST
      Its API biz spans more than 80 countries, including regulated markets of the US, Canada, Europe and Japan. Glenmark, which entered into the API...
      Sun Pharma acquires Japan Pola Pharma to strengthen dermatology segment

      Sun Pharma acquires Japan Pola Pharma to strengthen dermatology segment

      Farhat Nasim4 Jan 2019 12:38 PM IST
      Sun Pharma had entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and...
      Most patients not using online medical portals in US: Report

      Most patients not using online medical portals in US: Report

      Farhat Nasim4 Jan 2019 11:51 AM IST
      In a nationally representative survey, researchers found that nearly two-thirds of insured participants had not used online medical portals in the...
      Relief for online pharmacy traders: Madras High Court vacates stay on sale of online drugs

      Relief for online pharmacy traders: Madras High Court vacates stay on sale of online drugs

      Farhat Nasim3 Jan 2019 1:41 PM IST
      Chennai: A sigh of relief comes for the online pharmacy traders and patients purchasing drugs via online pharmacies after the Madras High Court...
      Alembic Pharma gets USFDA nod for Pramipexole Dihydrochloride extended-release tablets

      Alembic Pharma gets USFDA nod for Pramipexole Dihydrochloride extended-release tablets

      Farhat Nasim3 Jan 2019 9:45 AM IST
      The approval from the United States Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Pramipexole...
      Drug companies greet 2019 with U.S. price hikes

      Drug companies greet 2019 with U.S. price hikes

      Farhat Nasim3 Jan 2019 9:00 AM IST
      The overall number of price hikes was down by around a third from last year, when drugmakers raised prices on more than 400 medicines, according to...
      Medical Insurance Co will have to pay interest for mediclaim payout delay: Maharashtra Consumer Forum

      Medical Insurance Co will have to pay interest for mediclaim payout delay: Maharashtra Consumer Forum

      Farhat Nasim2 Jan 2019 1:22 PM IST
      Mumbai: Medical insurance is considered a form of long-term savings for citizens and enables them to pay for health checkups, emergency medical costs...
      After JnJ, baby products by Himalaya and Chicco under CDSCO scanner

      After JnJ, baby products by Himalaya and Chicco under CDSCO scanner

      Farhat Nasim2 Jan 2019 1:11 PM IST
      New Delhi: With the huge hue and cry relating to the Johnson and Johnson's baby talcum power and its probable link to cancer taking centre stage, many...
      Make in India in Pharmaceutical sector: Government prefers domestic drugs for public procurement

      Make in India in Pharmaceutical sector: Government prefers domestic drugs for public procurement

      Farhat Nasim2 Jan 2019 11:52 AM IST
      The Department of Industrial Policy and Promotion (DIPP) had identified DoP as the nodal department for implementing the provisions related to goods,...
      Aurobindo Pharma USA recalls 80 lots of BP drug from America

      Aurobindo Pharma USA recalls 80 lots of BP drug from America

      Farhat Nasim2 Jan 2019 9:30 AM IST
      Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan Tablets USP were distributed nationwide to Aurobindo Pharma USA Inc's...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok